Comparison of contrast-enhanced multi-station MR angiography and digital subtraction angiography of the lower extremity arterial disease

Journal of Magnetic Resonance Imaging

Volumn 37, Issue 6, 2013, Pages 1427-1435

  Burbelko, Mykhaylo ^a   Augsten, Michael ^a   Kalinowski, Marc O ^a   Heverhagen, Johannes T ^a,b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

digital subtraction angiography; MR angiography; sensitivity; specificity

Indexed keywords

GADOBUTROL;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; LEG ANGIOGRAPHY; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; STANDARD; THIGH;

AGED; ANGIOGRAPHY, DIGITAL SUBTRACTION; ARTERIAL OCCLUSIVE DISEASES; CONTRAST MEDIA; FEMALE; HUMANS; LOWER EXTREMITY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; ORGANOMETALLIC COMPOUNDS; PERIPHERAL ARTERIAL DISEASE; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SWITZERLAND;

EID: 84878223932     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23944     Document Type: Article

References (38)

1. Diehm C, Schuster A, Allenberg JR, et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004; 172: 95-105.
2. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: 381-386.
3. Leskinen Y, Salenius JP, Lehtimaki T, Huhtala H, Saha H,. The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. Am J Kidney Dis 2002; 40: 472-479.
4. Orchard TJ, Strandness DE Jr,. Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association September 18-20, 1992 New Orleans, Louisiana. Circulation 1993; 88: 819-828.
5. Schillinger M, Exner M, Mlekusch W, et al. Endovascular revascularization below the knee: 6-month results and predictive value of C-reactive protein level. Radiology 2003; 227: 419-425.
6. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG,. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45 (Suppl S): S5-S67.
7. Achenbach M, Figiel JH, Burbelko M, Heverhagen JT,. Prospective comparison of image quality and diagnostic accuracy of 0.5 molar gadobenate dimeglumine and 1.0 molar gadobutrol in contrast-enhanced run-off magnetic resonance angiography of the lower extremities. J Magn Reson Imaging 2010; 32: 1166-1171.
8. Attenberger UI, Haneder S, Morelli JN, Diehl SJ, Schoenberg SO, Michaely HJ,. Peripheral arterial occlusive disease: evaluation of a high spatial and temporal resolution 3-T MR protocol with a low total dose of gadolinium versus conventional angiography. Radiology 2010; 257: 879-887.
9. Cornfeld D, Mojibian H,. Clinical uses of time-resolved imaging in the body and peripheral vascular system. AJR Am J Roentgenol 2009; 193: W546-W557.
10. Ersoy H, Rybicki FJ,. MR angiography of the lower extremities. AJR Am J Roentgenol 2008; 190: 1675-1684.
11. Haider CR, Glockner JF, Stanson AW, Riederer SJ,. Peripheral vasculature: high-temporal- and high-spatial-resolution three-dimensional contrast-enhanced MR angiography. Radiology 2009; 253: 831-843.
12. Heverhagen JT, Funck RC, Schwarz U, et al. Kinetic evaluation of an i.v. bolus of MR contrast media. Magn Reson Imaging 2001; 19: 1025-1030.
13. Heverhagen JT, Reitz I, Pavlicova M, Levine AL, Klose KJ, Wagner HJ,. The impact of the dosage of intravenous gadolinium-chelates on the vascular signal intensity in MR angiography. Eur Radiol 2007; 17: 626-637.
14. Heverhagen JT, Wright CL, Schmalbrock P, Knopp MV,. Dose comparison of single versus double dose in contrast-enhanced magnetic resonance angiography of the renal arteries: intra-individual cross-over blinded trial using Gd-DTPA. Eur Radiol 2009; 19: 67-72.
15. Knopp MV, Giesel FL, von Tengg-Kobligk H, et al. Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine. J Magn Reson Imaging 2003; 17: 694-702.
16. Kramer H, Nikolaou K, Sommer W, Reiser MF, Herrmann KA,. Peripheral MR angiography. Magn Reson Imaging Clin N Am 2009; 17: 91-100.
17. Lee HM, Wang Y, Sostman HD, et al. Distal lower extremity arteries: evaluation with two-dimensional MR digital subtraction angiography. Radiology 1998; 207: 505-512.
18. Nael K, Fenchel M, Krishnam M, Laub G, Finn JP, Ruehm SG,. High-spatial-resolution whole-body MR angiography with high-acceleration parallel acquisition and 32-channel 3.0-T unit: initial experience. Radiology 2007; 242: 865-872.
19. Visser K, Hunink MG,. Peripheral arterial disease: gadolinium-enhanced MR angiography versus color-guided duplex US-a meta-analysis. Radiology 2000; 216: 67-77.
20. Wang Y, Lee HM, Khilnani NM, et al. Bolus-chase MR digital subtraction angiography in the lower extremity. Radiology 1998; 207: 263-269.
21. Wyttenbach R, Gianella S, Alerci M, Braghetti A, Cozzi L, Gallino A,. Prospective blinded evaluation of Gd-DOTA- versus Gd-BOPTA-enhanced peripheral MR angiography, as compared with digital subtraction angiography. Radiology 2003; 227: 261-269.
22. BfArM. Gadolinium-haltige Kontrastmittel für MRT: Aktualisierter Stand zur Anzahl von Berichten über NSF-Risiko. Available at: www.bfarm.de. Accessed December 12, 2008.
23. Frenzel T, Lengsfeld P, Schirmer H, Hutter J, Weinmann HJ,. Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C. Invest Radiol 2008; 43: 817-828.
24. Krefting I,. Gadolinium-Based Contrast Agents (GBCAs) and the NSF risk: regulatory update. Available at: www.fda.gov. Accessed January 21, 2011.
25. Sieber MA, Pietsch H, Walter J, Haider W, Frenzel T, Weinmann HJ,. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media. Invest Radiol 2008; 43: 65-75.
26. Ihnat DM, Mills JL,. Current assessment of endovascular therapy for infrainguinal arterial occlusive disease in patients with diabetes. J Am Podiatr Med Assoc 2010; 100: 424-428.
27. Zimmermann A, Wendorff H, Schuster T, Auer F, Berger H, Eckstein HH,. Interobserver agreement of the TASC II classification for supra- and infrainguinal lesions. Eur J Vasc Endovasc Surg 2010; 39: 586-590.
28. Pomposelli F,. Arterial imaging in patients with lower extremity ischemia and diabetes mellitus. J Vasc Surg 2010; 52 (Suppl): 81S-91S.
29. Hentsch A, Aschauer MA, Balzer JO, et al. Gadobutrol-enhanced moving-table magnetic resonance angiography in patients with peripheral vascular disease: a prospective, multi-centre blinded comparison with digital subtraction angiography. Eur Radiol 2003; 13: 2103-2114.
30. Menke J, Larsen J,. Meta-analysis: accuracy of contrast-enhanced magnetic resonance angiography for assessing steno-occlusions in peripheral arterial disease. Ann Intern Med 2010; 153: 325-334.
31. Bui BT, Miller S, Mildenberger P, Sam A, Sheng R,. Comparison of contrast-enhanced MR angiography to intraarterial digital subtraction angiography for evaluation of peripheral arterial occlusive disease: results of a phase III multicenter trial. J Magn Reson Imaging 2010; 31: 1402-1410.
32. Thurnher S, Miller S, Schneider G, et al. Diagnostic performance of gadobenate dimeglumine enhanced MR angiography of the iliofemoral and calf arteries: a large-scale multicenter trial. AJR Am J Roentgenol 2007; 189: 1223-1237.
33. Wang CC, Liang HL, Hsiao CC, et al. Single-dose time-resolved contrast enhanced hybrid MR angiography in diagnosis of peripheral arterial disease: compared with digital subtraction angiography. J Magn Reson Imaging 2010; 32: 935-942.
34. Nielsen YW, Eiberg JP, Logager VB, Just S, Schroeder TV, Thomsen HS,. Whole-body magnetic resonance angiography with additional steady-state acquisition of the infragenicular arteries in patients with peripheral arterial disease. Cardiovasc Intervent Radiol 2010; 33: 484-491.
35. Hodnett PA, Koktzoglou I, Davarpanah AH, et al. Evaluation of peripheral arterial disease with nonenhanced quiescent-interval single-shot MR angiography. Radiology 2011; 260: 282-293.
36. Lanzman RS, Schmitt P, Kropil P, Blondin D,. Nonenhanced MR angiography techniques]. Rofo 2011; 183: 913-924.
37. Bley TA, Duffek CC, Francois CJ, et al. Presurgical localization of the artery of Adamkiewicz with time-resolved 3.0-T MR angiography. Radiology 2010; 255: 873-881.
38. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD Initiative. Radiology 2003; 226: 24-28.